Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Albumin human 4.5% solution for infusion 50ml bottles
0902022A0AAAKAK
|
Human albumin | Albumin solution | Nutrition and Blood | No data available |
|
Albumin human 5% solution for infusion 100ml bottles
0902022A0AAALAL
|
Human albumin | Albumin solution | Nutrition and Blood | No data available |
|
Albumin human 5% solution for infusion 250ml bottles
0902022A0AAAMAM
|
Human albumin | Albumin solution | Nutrition and Blood | No data available |
|
Albumin human 5% solution for infusion 500ml bottles
0902022A0AAANAN
|
Human albumin | Albumin solution | Nutrition and Blood | No data available |
|
Albunorm 20% solution for infusion 100ml bottles
0902022A0BEADAC
|
Albunorm | Albumin solution | Nutrition and Blood | No data available |
|
Albunorm 20% solution for infusion 50ml bottles
0902022A0BEAEAB
|
Albunorm | Albumin solution | Nutrition and Blood | No data available |
|
Albunorm 5% solution for infusion 100ml bottles
0902022A0BEAAAL
|
Albunorm | Albumin solution | Nutrition and Blood | No data available |
|
Albunorm 5% solution for infusion 250ml bottles
0902022A0BEABAM
|
Albunorm | Albumin solution | Nutrition and Blood | No data available |
|
Albunorm 5% solution for infusion 500ml bottles
0902022A0BEACAN
|
Albunorm | Albumin solution | Nutrition and Blood | No data available |
|
Albupore tape 1.25cm
20100000500
|
Albupore tape 1.25cm | Surgical Adhesive Tape | Dressings | No data available |
|
Albupore tape 2.5cm
20100000501
|
Albupore tape 2.5cm | Surgical Adhesive Tape | Dressings | No data available |
|
Albupore tape 5cm
20100000502
|
Albupore tape 5cm | Surgical Adhesive Tape | Dressings | No data available |
|
Alclometasone 0.05% ointment
1304000B0AABABA
|
Alclometasone dipropionate | Alclometasone dipropionate | Skin | No data available |
|
Alcoderm cream
130201000BBASAR
|
Proprietary compound emollients | Other emollient preparations | Skin | No data available |
|
Alcoderm lotion
130201000BBATAS
|
Proprietary compound emollients | Other emollient preparations | Skin | No data available |
|
Aldanex skin protectant
23803438000
|
Aldanex skin protectant | Skin Fillers And Protectives | Stoma Appliances | No data available |
|
Aldesleukin 18million unit inj vials
0802040AQAAAAAA
|
Aldesleukin | Aldesleukin | Malignant Disease and Immunosuppression | No data available |
|
Aldioxa 0.22% / Chloroxylenol 0.5% powder
131200000AAAHAH
|
Generic compound preparation BNF 1312000 | Other antiperspirant preparations | Skin | No data available |
|
Aldon C drainable night drainage bag
22605406000
|
Aldon C drainable night drainage bag | Night Drainage Bags | Incontinence Appliances | No data available |
|
Aldon CVT drainable night drainage bag
22605406002
|
Aldon CVT drainable night drainage bag | Night Drainage Bags | Incontinence Appliances | No data available |
|
Aldurazyme 500units/5ml concentrate for inf vials
0908010ABBBAAAA
|
Aldurazyme | Laronidase | Nutrition and Blood | No data available |
|
Alecensa 150mg capsules
0801050CDBBAAAA
|
Alecensa | Alectinib | Malignant Disease and Immunosuppression | No data available |
|
Alectinib 150mg capsules
0801050CDAAAAAA
|
Alectinib | Alectinib | Malignant Disease and Immunosuppression | No data available |
|
Alembicol D oil
0913431B0BBAAAA
|
Alembicol D ready to serve 100% MCT liquid | Ready to serve 100% MCT liquid (0913431) | Nutrition and Blood | No data available |
|
Alemtuzumab 12mg/1.2ml solution for infusion vials
0802030E0AAABAB
|
Alemtuzumab | Alemtuzumab | Malignant Disease and Immunosuppression | No data available |
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.